CSPC Innovation Soars 8.81%, Hits Intraday High of CNY 42.88

CSPC Innovation Pharmaceutical Co., Ltd. has experienced significant activity today, with the stock rising by 8.81% as of July 20, 2026. The stock reached an intraday high of CNY 42.88, marking a notable performance against the backdrop of the China Shanghai Composite, which only gained 0.85% on the same day. Over the past week, CSPC Innovation has shown a robust increase of 10.84%, while its one-month performance stands at an impressive 73.78%. However, the company has faced challenges over the longer term, with a one-year performance decline of 25.39%, contrasting sharply with the China Shanghai Composite's gain of 7.41% during the same period. Despite the recent uptick, CSPC Innovation's financial metrics reveal underlying concerns. The company has reported negative results for the last ten consecutive quarters, with a return on capital employed (ROCE) of -9.81% and a net profit of CNY -95.43 million, reflecting a decline of 47.33%. The stock's high dividend yield of 0% further emphasizes its current financial position. As a large-cap player in the FMCG industry, CSPC Innovation continues to navigate a complex market landscape.